CLINICAL_TRIALS
trial_result
· 2014-07-25
Clinical Trial Update: TASALL - TachoSil® Against Liquor Leak [Phase 3]
Summary
Phase 3 trial evaluating TachoSil for preventing cerebrospinal fluid leaks has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Cerebrospinal Fluid Leaks | Phase 3 | Status: COMPLETED | Results posted: 2014-07-25